Government of Mozambique   Report issue

Government Phase 2 Phase 3 Phase 4
Founded: Maputo Mozambique (1990)

Organization Overview

First Clinical Trial
2007
NCT00393679
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Centro de Investigação em Saude de Manhiça | Centro de Investigacao em Saude de Manhica | Centro de Investigação em Saúde de Manhiça | INS-CISPOC | Instituto Nacional de Saúde | Instituto Nacional de Saúde (INS), Mozambique | Instituto Nacional de Saúde, Mozambique | Ministry of Health, Instituto Nacional de Saude, Mozambique | Ministry of Health, Mozambique | Mozambique Institute for Health Education and Research | Mozambique Ministry of Health

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cytomegalovirus Infections (Phase 3)

Elephantiasis (Phase 4)

Elephantiasis, Filarial (Phase 4)

Filariasis (Phase 4)

HIV Infections (Phase 2)

Malaria (Phase 4)

Malaria, Falciparum (Phase 2)

Pneumonia (Phase 3)

Trachoma (Phase 4)

Tuberculosis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 42